Pcn125 - First Insights Into Comparing Expenditures for Targeted Therapy and Survival in NSCLC

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.208

Full Text

Abstract

Available in

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

First Insights Into Non-Invasive Administration Routes for Non-Viral Gene Therapy

English

Comparing State-Only Expenditures for AIDS.

American Journal of Public Health

Occupational Health

English

Expanding Targeted Therapies for NSCLC

Cancer Discovery

English

Association of First-In-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma

Cancer Research

English

Denosumab for Bone Diseases: Translating Bone Biology Into Targeted Therapy

European Journal of Endocrinology

English

Translating Molecular Insights in Autoimmunity Into Effective Therapy

Annual Review of Immunology

English

P3.01-65 First-Line Radical Local Therapy May Provide Additional Survival Gain for Patients With EGFR-Mutant Metastatic NSCLC Receiving TKIs

Journal of Thoracic Oncology

Respiratory Medicine

English

Insights Into Deoxyribonucleoside Therapy for Mitochondrial TK2 Deficient mtDNA Depletion

Molecular Biology

English

Insights Into the Roles of Midazolam in Cancer Therapy

Evidence-based Complementary and Alternative Medicine

Alternative Medicine

English